Clinical Trial Update: The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating concurrent chemoradiotherapy for stage II nasopharyngeal carcinoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED